Guided Self-help for Anxiety - a Patient Preference Trial
Launched by UNIVERSITY OF SHEFFIELD · Nov 2, 2018
Trial Information
Current as of May 29, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients have self-referred or been referred by their GP or other health or social care professional for a step 2 intervention for treatment of a common mental health problem,
- • patients meet criteria for an anxiety disorder on MINI screening interview assessment and also met caseness on the BAI (as defined by a score of \>10 on the BAI at assessment).
- • Patients want to engage in GSH to address the anxiety disorder
- • patients are motivated to engage in treatment and can attend six sessions of face-to-face GSH.
- Exclusion Criteria:
- • engaging in any another IAPT step 2 interventions.
- • Do not meet criteria for an anxiety disorder as defined by the MINI and the BAI score.
- • Meet criteria for depression and a comorbid anxiety disorder, as identified by the BAI and MINI, where the depression is more severe and is the patient's main concern.
- • Have a severe/chronic mental health problem and are already involved in psychiatric or secondary care mental health services.
- • Have substance misuse issues that would interfere with engagement with the GSH.
- • Have a diagnosed learning disability that precludes engagement in GSH.
- • Have a diagnosis of social phobia or PTSD
About University Of Sheffield
The University of Sheffield is a prestigious research institution located in the United Kingdom, renowned for its commitment to advancing medical science and improving patient outcomes through innovative clinical research. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, facilitating cutting-edge studies that address critical health challenges. The University of Sheffield's clinical trials are designed to adhere to rigorous ethical standards and regulatory requirements, ensuring the reliability and integrity of their findings while contributing to the global body of medical knowledge. Through its dedication to excellence in research and education, the university aims to translate scientific discoveries into real-world applications that enhance health and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oldham, Lancashire, United Kingdom
Patients applied
Trial Officials
Steve Kellett
Study Director
University of Sheffield
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials